Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

This publication has 120 references indexed in Scilit:

• Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
  Journal of the American Academy of Dermatology, 2008
• Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic
  Cancer Treatment Reviews, 2007
• Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes
  Life Sciences, 2006
• The paradox of pro-inflammatory cytokines in cancer
  Cancer and Metastasis Reviews, 2006
• Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin
  Journal of Pharmaceutical and Biomedical Analysis, 2006
• The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo
  Prostate Cancer and Prostatic Diseases, 2006
• Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study
  Digestive Diseases and Sciences, 2005
• Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1
  Oncogene, 2005
• Cancer genes and the pathways they control
  Nature Medicine, 2004
• Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia
  Cancer Letters, 1992